相关实验视频
Updated: Jun 12, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
拼接因子QKI通过调节皮质甲状腺癌中E-Syt2的替代拼接来抑制转移
Mengya Zhao1, Yu Jin2, Zhongyi Yan3
1Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University & The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center Nanjing, Nanjing Medical University, Nanjing, China; Wuxi People's Hospital, Wuxi Medical Center Nanjing & Department of Immunology, School of Basic Medical Science & Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China; The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Nanjing, China.
震动蛋白 (QKI) 降低调节通过改变拼接来促进乳头甲状腺癌 (PTC) 的生长和转移. 针对QKI或其相关的拼接事件可能为PTC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 替代拼接 (AS) 与癌症的发展和进展有关.
- 有助于乳头甲状腺癌 (PTC) 转移的异常AS事件尚不清楚.
研究的目的:
- 研究拼接因子动蛋白 (QKI) 在PTC转移中的作用.
- 阐明将QKI与PTC进展联系起来的分子机制.
主要方法:
- 在PTC患者样本中分析QKI表达和与生存的相关性.
- 在体外和体外功能研究,以评估QKI对PTC细胞行为的影响.
- 机械研究涉及扩展型突触胺2 (E-Syt2) 的替代拼接和与长非编码RNA乙氨基基酸颗粒发育转录 (EGOT) 的相互作用.
主要成果:
- 在PTC中,QKI显著下调,并与患者的不良结果相关.
- 减少QKI表达增强了PTC细胞生长和转移.
- 较低的QKI水平诱导了e-Syt2的14外子保留,产生了致癌的e-Syt2长异型 (e-Syt2L).
- 过度表达的EGOT通过抑制USP25介导的deubiquitination和降解来抑制QKI活性.
结论:
- 在PTC转移中,QKI作为瘤抑制剂起作用.
- QKI/E-Syt2拼接轴代表了一种驱动PTC转移的新机制.
- 针对异常拼接事件,特别是涉及QKI的事件,为PTC提供了潜在的治疗途径.
相关概念视频
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

